Share the post "Mutual Fund Data: Stock Market today Insights for – 06 Aug 2024"
Below is a summary of the recent activities observed within the mutual fund for the clients: Quant Mutual Fund. Let’s delve into the details below to explore further.
| Company Logo | Company | Client Name | Buy/Sell | Qty Traded | Price | Trader Name |
|---|---|---|---|---|---|---|
 |
Zydus Wellness | Quant Mutual Fund | Buy | 1M | 2201.40 | Threpsi Care Llp |
The 1M shares of Zydus Wellness have been purchased by the by Quant Mutual Fund through mutual funds at a price of ₹2201.40 per shareand it is sold by Threpsi Care Llp at a price of ₹2201.40 per share.
| Company Logo | Company | Client Name | Buy/Sell | Qty Traded | Price | Trader Name |
|---|---|---|---|---|---|---|
|
Zydus Wellness | Quant Mutual Fund | Buy | 1M | 2201.40 | Threpsi Care Llp |
Zydus Wellness shares totaling 1M were purchased by the by Quant Mutual Fund of MutualFund, with the transaction occurring at a price of ₹2201.40 per share. Subsequently, the shares were sold by Threpsi Care Llp at the same price per share.
Zydus Wellness Limited
8,410.00
Net Sales
1,477.00
Net Profit
8,460.00
Total Income
6,944.00
Expenditure
2,267
Current Price
14,428
Market Cap
The latest financial figures for Zydus Wellness Limited indicate a strong performance. The company achieved net sales of ₹8,410.00 million and total income of ₹8,460.00 million for the quarter. Expenditure was ₹6,944.00 million, resulting in a net profit of ₹1,477.00 million. Earnings per Share (EPS) for continuing operations stood at ₹23.21. The report also shows other income of ₹50.00 million, finance costs of ₹36.00 million, and employee benefit expenses of ₹594.00 million. Depreciation and amortization expenses totaled ₹51.00 million. Current tax expense was ₹1.00 million and deferred tax expense was ₹38.00 million. Total comprehensive income for the period was ₹1,476.00 million, with other comprehensive income net of taxes at ₹-1.00 million.
Valued at ₹14,428 crore, the company's stock trades at ₹2,267, with historical highs and lows of ₹2,484 / 1,440. The P/E ratio of 47.4 reflects a high stock valuation. The book value is ₹842, and the dividend yield is 0.22%. ROCE is at 5.33%, and ROE is 5.32%. The company’s minimal debt-to-equity ratio of 0.06 contrasts with its negative net cash flow of ₹201 crore. The Piotroski score is 5.00, and the Graham Number of ₹952 provides insight into the stock’s valuation. The Price-to-Book (P/B) ratio of 2.69 indicates a premium valuation.
